BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11449103)

  • 1. Targeted topical steroid therapy in sudden sensorineural hearing loss.
    Kopke RD; Hoffer ME; Wester D; O'Leary MJ; Jackson RL
    Otol Neurotol; 2001 Jul; 22(4):475-9. PubMed ID: 11449103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transtympanic steroids in refractory sudden hearing loss. Personal experience.
    Dallan I; Bruschini L; Nacci A; Fattorp B; Traino AC; Rognini F; Ferraro G; Bruschini P
    Acta Otorhinolaryngol Ital; 2006 Feb; 26(1):14-9. PubMed ID: 18383752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
    Herr BD; Marzo SJ
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):527-31. PubMed ID: 15806039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic methylprednisolone for sudden sensorineural hearing loss.
    Kiliç R; Safak MA; Oğuz H; Kargin S; Demirci M; Samim E; Ozlüoğlu LN
    Otol Neurotol; 2007 Apr; 28(3):312-6. PubMed ID: 17414035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.
    Van Wijck F; Staecker H; Lefebvre PP
    Acta Otolaryngol; 2007 Oct; 127(10):1012-7. PubMed ID: 17851934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F; Staecker H; Keithley E; Lefebvre PP
    Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy.
    Chen Y; Wen L; Hu P; Qiu J; Lu L; Qiao L
    J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):640-5. PubMed ID: 21144358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study.
    Lefebvre PP; Staecker H
    Acta Otolaryngol; 2002 Oct; 122(7):698-702. PubMed ID: 12484644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transtympanic steroids as a salvage therapy in sudden hearing loss: preliminary results.
    Dallan I; Bruschini L; Nacci A; Bruschini P; Traino C; Rognini F; Fattori B
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):247-52. PubMed ID: 16679810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audiometric outcomes of topical IGF1 treatment for sudden deafness refractory to systemic steroids.
    Nakagawa T; Ogino-Nishimura E; Hiraumi H; Sakamoto T; Yamamoto N; Ito J
    Otol Neurotol; 2012 Aug; 33(6):941-6. PubMed ID: 22772021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.
    Rauch SD; Halpin CF; Antonelli PJ; Babu S; Carey JP; Gantz BJ; Goebel JA; Hammerschlag PE; Harris JP; Isaacson B; Lee D; Linstrom CJ; Parnes LS; Shi H; Slattery WH; Telian SA; Vrabec JT; Reda DJ
    JAMA; 2011 May; 305(20):2071-9. PubMed ID: 21610239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous versus Sequential Intratympanic Steroid Treatment for Severe-to-Profound Sudden Sensorineural Hearing Loss.
    Yoo MH; Lim WS; Park JH; Kwon JK; Lee TH; An YH; Kim YJ; Kim JY; Lim HW; Park HJ
    Audiol Neurootol; 2016; 21(6):399-405. PubMed ID: 28384627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G; Herráiz C
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transtympanic steroids for treatment of sudden hearing loss.
    Gianoli GJ; Li JC
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):142-6. PubMed ID: 11555744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden Pediatric Hearing Loss: Comparing the Results of Combined Treatment (Intratympanic Dexamethasone and Systemic Steroids) With Systemic Steroid Treatment Alone.
    Övet G; Alataş N; Güzelkara F
    Otol Neurotol; 2016 Jul; 37(6):742-7. PubMed ID: 27223677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.
    Tsounis M; Psillas G; Tsalighopoulos M; Vital V; Maroudias N; Markou K
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):103-110. PubMed ID: 29168028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic methylprednisolone as first-line therapy in sudden sensorineural hearing loss: preliminary results from a case-control series.
    Dallan I; Fortunato S; Casani AP; Panicucci E; Berrettini S; Lenzi R; Nacci A
    J Laryngol Otol; 2011 Oct; 125(10):1004-8. PubMed ID: 21806858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss.
    She W; Dai Y; Du X; Yu C; Chen F; Wang J; Qin X
    Otolaryngol Head Neck Surg; 2010 Feb; 142(2):266-71. PubMed ID: 20115986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.